Dysuria

07/16/2005 - "Three days' treatment with trimethoprim significantly reduced dysuria in women whose urine dipstick test was negative. "
07/16/2005 - "The median time for resolution of dysuria was three days for trimethoprim compared with five days for placebo (P = 0.002). "
01/01/1982 - "Dysuria-frequency in 78 patients was treated for 3 consecutive days with 300 mg trimethoprim administered in a single dose at night. "
01/01/1982 - "Experience of three-day trimethoprim therapy for dysuria-frequency in primary health care."
05/01/1987 - "A single dose of trimethoprim seems to be safe and effective in the treatment of acute dysuria/pyuria syndrome in women."

08/30/2004 - "These results indicate that tamsulosin will be useful in the treatment of dysuria associated with lower urinary tract symptoms in women as well as men."
03/01/2005 - "The use of prophylactic tamsulosin resulted in a statistically lower dysuria severity score (difference of 2.7 vs 4.2, P < 0.005) at 1 month, with no discernible differences at 3, 6, 12 and 18 months. "
03/01/2012 - "Dysuria improved after tamsulosin treatment was initiated, and abdominal magnetic resonance imaging (MRI) showed disappearance of the cyst. "
11/01/2001 - "Though he had been treated with tamsulosin hydrochloride 0.2 mg/day as diagnosis of benign prostatic hyperplasia, he experienced severe dysuria and wanted to undergo transurethral resection of the prostate. "

10/05/2008 - "Prostate volume is decreased and mechanical component of dysuria is improved by treating for a long time (months, years) with 5-alpha-reductase finasteride which contains hormone. "
09/14/2003 - "Prostate volume is decreased and mechanical component of dysuria is improved by treating for long time (months, years) with 5 alfa reductase finasterid which contain hormone. "
01/01/1990 - "Objective response rates of the prostate, bone metastases, serum prostatic acid phosphatase and soft tissue metastases, and subjective dysuria and pain responses were comparable to those found with conventional hormone therapy. "

01/01/1990 - "A multicenter, double-blind, placebo-controlled trial of the efficacy of prazosin in the treatment of dysuria associated with benign prostatic hypertrophy."
01/01/1990 - "Prazosin HCl was administered in dosages of 1.5-4.5 mg/day for 4 weeks to 40 patients suffering from dysuria accompanying prostatic hyperplasia. "
01/01/1990 - "Clinical studies on the effectiveness of prazosin HCl (Minipress tablets) in the treatment of dysuria accompanying benign prostatic hyperplasia."

05/01/2009 - "Twelve of 23, 18-week-old nude mice developed dysuria after estrogen pellet implantation. "
03/01/2004 - "Although urogenital complaints, such as recurrent lower urinary tract infections (UTI), and dysuria, are commonly encountered in elderly women, few women have participated in randomized studies of estrogen therapy for this condition. "
08/18/2008 - "A case of MESTK which uncommonly occurred in a 16-year old adolescent male presented with dysuria and a large mass in the right renal region without a history of estrogen/progestogen treatment and/or obesity or urogenital surgery. "
08/01/1996 - "Treatment with low potency estrogens given locally or orally has been shown to alleviate urgency, urge incontinence, frequency, nocturia and dysuria, but there is no conclusive evidence that estrogens alone improve or cure stress incontinence. "
03/01/1995 - "Furthermore, systemic estrogen replacement appears to alleviate the symptoms of urgency, urge incontinence, frequency, nocturia and dysuria, and low-dose topical estrogen is effective in the management of atrophic vaginitis. "

03/01/1998 - "Recent clinical observations indicate that ibuprofen may alleviate the radiation-induced dysuria that almost invariably occurs during radiation therapy for prostate cancer. "
01/01/2010 - "Eighty otherwise healthy women aged 18 to 85 years, presenting with at least one of the main UTI symptoms dysuria and frequency and without any complicating factors, were randomly assigned to receive either ibuprofen 3 x 400 mg oral or ciprofloxacin 2 x 250 mg (+1 placebo) oral, both for three days.Intensity"
09/01/2002 - "On the basis of our anecdotal clinical observations that nonsteroidal anti-inflammatory agents relieved dysuria during radiotherapy for patients with prostate cancer, we conducted a Phase III randomized trial of ibuprofen vs. placebo for patients who had an increase in acute urinary symptoms. "

01/01/1982 - "The "irritative" symptoms of prostatic hypertrophy, including nocturnal frequency and dysuria, were improved after Nicergoline significantly more than after placebo. "
01/01/1987 - "A double-blind prospective trial investigated effects of Nicergoline on micturitional disorders in 60 selected patients with dysuria in the absence of prostate hypertrophy and neurologic disease. "

05/01/1984 - "Of 210 women who were experiencing dysuria, frequent urination, pyuria, and significant bacteriuria and who were treated with a single 3-g dose of amoxicillin, 165 (79%) were cured of their original infections. "
01/01/1990 - "The results of this study suggest that single-dose treatment with fosfomycin trometamol is effective and acceptable as a conventional course of amoxycillin clavulanate for the treatment of simple acute dysuria and/or frequency with infection."

01/01/1986 - "Dysuria, bacteriuria, leucocyturia and antibiotic or chemotherapeutic consumption showed a significant reduction under OM-8930 in comparison with the placebo. "
06/01/2002 - "In all studies, the Uro-Vaxom group was statistically significant and clinically relevant superior to control with respect to the reduction of the frequency of UTIs and to dysuria, bacteriuria and leucocyturia. "

01/01/2015 - "Moreover in clinical trials, both versus placebo or versus active comparators, flavoxate treatment was associated with a significant improvement in different low urinary tract symptoms, such as diurnal and night frequency, urgency and urinary incontinence, suprapubic pain, dysuria, hesitancy and burning. "

12/01/2008 - "The therapeutic efficacy was evaluated by changes in TCM symptoms after treatment (including frequency of night urination, degree of dysuria, condition of urinary thread, soreness and weakness in loin and knees, lower abdominal distention, spiritless and general weakness), the International Prostate Syndrome Score (I-PSS), maximum flow rate (Qmax), residual urine volume and prostate volume. "
09/01/1994 - "The dysuria of the patients in both groups was improved after treatment. "
10/01/2014 - "After treatment, the score for symptoms of first urination, urinary time, urinary volume, 24 h remaining urinary volume, incidence of uroschesis, and rate of controlling dysuria were compared to evaluate the curative effect of preventing post-operative dysuria. "
03/01/2008 - "Nine patients complained of dysuria 1 month after treatment. "
01/01/1995 - "Dysuria was reported by 14 patients before treatment, by none after treatment. "

02/01/2015 - "Dysuria is common in pelvic, especially prostate radiotherapy, but there is not any established and confirmed treatment for this therapeutic side effect. "
02/01/2015 - "Botanicals: an alternative remedy to radiotherapy-induced dysuria."
01/01/2008 - "Patients with a large prostate volume have a great risk of irritative/obstructive symptoms (particularly dysuria) in the acute radiotherapy phase. "
03/01/2005 - "The dysuria resolved faster in patients implanted with 103Pd but was unaffected by the use of supplemental radiotherapy and/or androgen deprivation therapy. "
03/15/2003 - "The isotope, supplemental external beam radiotherapy, hormonal status, minimal dose received by 90% of the prostate, and urethral dose did not predict for dysuria. "

05/01/2008 - "After stent removal, the Sp group reported significantly greater improvements in the IPSS irritative subscore (5 weeks: Sp = -4.0 versus SOC = -2.7, P = 0.029; 8 weeks: Sp = -5.0 versus SOC = -4.0, P = 0.050), individual voiding (stream strength and dysuria), and irritative (frequency and urgency) symptoms and bother (5 weeks: Sp = -4.0 versus SOC = -2.3, P = 0.002; 8 weeks: Sp = -5.0 versus SOC = -3.1, P = 0.001). "
01/01/2015 - "The analysis of data showed that the unpleasant symptoms caused by stent were encountered more frequently at 7 days after stent insertion, in terms of urinary frequency, dysuria, urgency and macroscopic haematuria, this difference being statistically significant (p<0.05). "
03/01/2014 - "Procedure-related, postoperative (< 7 days), short-term (7 to 30 days), and long-term (> 30 days) complications occurred in 8.7% (6/69; 7/79 ureters), 9.1% (6/66), 9.8% (6/61), and 33% (20/60) of cats, respectively; most of these complications were minor and associated with intermittent dysuria or the need for ureteral stent exchange. "
07/01/2010 - "The stent had migrated into the bladder causing dysuria and a poor stream of urine. "
07/01/2007 - "Urgency and dysuria as well as a worse quality of life were significantly more common in the patients who had longer stents."

02/01/2015 - "For patients undergoing neurosurgery and associated short-term indwelling urinary catheterization, an early catheter clamping protocol is effective in facilitating bladder function, reducing the rate of dysuria and making patients feel more comfortable after catheter removal. "
01/01/2012 - "Bladder catheter was inserted because of dysuria. "
11/01/2009 - "There were no significant differences in catheter time, dysuria, quality of life scores, or urinary flow parameters. "
10/01/2007 - "Severe acute urinary morbidity (SAUM) was defined as a dysuria frequency score of at least 4 (of 5), a dysuria severity score of at least 8 (of 10), an internation prostate symptom score (IPSS) elevated to at least 30 or 15 above preimplant value for 4 weeks, and/or requirement of a urinary catheter for at least 5 days. "
10/01/2007 - "Treatment was well tolerated, with only 3.7% of procedures developing retention requiring catheter placement; 20% of patients reported significant postimplant dysuria, mean duration of any dysuria being 7.5 days. "

01/01/1997 - "Pronounced dysuria, persistent pain are highly resistant to conventional chemotherapy. "
11/01/2003 - "Regional intra-arterial chemotherapy is a safe and effective technique for patients with advanced, muscle invasive bladder carcinoma and can improve the quality of life of most affected patients by decreasing the degree of hematuria and dysuria associated with this malignancy."
11/01/2003 - "Eight out of 15 patients with tumor-associated dysuria at the time of initiation of chemotherapy had significant pain relief at the end of the treatment. "
01/01/1996 - "In 90% after regional arterial chemotherapy, symptoms (pain, dysuria, hemorrhage) of bladder cancer ceased. "
12/01/1984 - "The chemotherapy improved acid phosphatase values in 5 out of 10 cases, alkaline phosphatase values in 3 out of 10 cases, dysuria in 4 out of 8 cases, nocturia in 1 out of 12 cases, residual urine in 5 out of 6 cases, lumbago in 6 out of 8 cases, and constitutional symptom in 6 out of 12 cases. "